Solvation Directed Design of Flavonoid Derivatives for Caspase Inhibition
Solvation Directed Design of Flavonoid Derivatives for Caspase Inhibition
批准号:
8606468
负责人:
Thomas Philip Kurtzman
金额:
$11.44万
依托单位国家:
美国
项目类别:
财政年份:
2012
资助国家:
美国
项目状态:
已结题
起止时间:
2012-04-10 至 2016-01-31
关键词:
3-DimensionalActive SitesAddressAdultAdverse effectsAffinityAmericanAreaBindingBinding ProteinsBiological AssayCaspaseCaspase InhibitorChargeChemicalsCollaborationsComputational TechniqueComputing MethodologiesDevelopmentDrug IndustryDrug PrescriptionsEffectivenessFDA approvedFlavonoidsGoalsHeadHealth BenefitKineticsLeadLengthLigand BindingLigandsMapsMarketingMechanicsMethodologyMethodsModificationMolecularMolecular BiologyOrganic ChemistryOutcomePharmaceutical PreparationsPhysicsPlayPriceProcessPropertyProtein FamilyProteinsPublic HealthResearchRoleRouteRunningShapesSpecificityTechniquesTechnologyTestingTheoretical StudiesThermodynamicsValidationWaterWorkanalogbasecombinatorialcomputer studiescostdesignimprovedinsightinterestmeetingsmembermolecular dynamicsmolecular recognitionprocess optimizationprofessorprogramstool
中文摘要
描述(由申请人提供):该项目寻求开发一种合理的设计方法,该方法利用强大的溶剂化分析工具Water Map来指导先导化合物的修饰,使它们与给定的目标有更大的亲和力。该方法将被用于设计对类黄酮化合物的修饰,以使得到的类似物特异性地和强烈地抑制Caspase蛋白质家族的成员。Water Map技术利用显式的分子动力学模拟和严格的统计力学理论处理来创建蛋白质活性部位的溶剂化化学势的近似三维图谱。这种方法解决了大多数旨在预测配体结合亲和力的计算方法中的两个众所周知的缺陷。首先,在保持计算效率的同时,它捕捉到了水溶剂化的基本分子长度尺度物理,而大多数旨在预测配体-蛋白质结合亲和力的方法都忽略了这一点。其次,它提供了具体的信息和对先导药物应该如何进行修饰的物理洞察力,例如生产能够与给定靶点具有更强亲和力和特异性的衍生物
由于这些功能,Water Map方法论在领先的优化过程中显示出巨大的帮助前景。合理设计更具特异性和更强的caspase家族抑制剂的类黄酮类类似物将作为测试案例,长期目标是开发一种适用于所有水合蛋白靶标的方法学。具体目标1寻求设计和实施一种合理的设计方法,该方法结合了Water Map技术提供的溶剂化信息,该技术能够指导修饰的设计,以使它们与给定的目标具有更高的亲和力。对特定目标1的评估将是特定目标2的目标,该目标是应用新的方法学来设计对类黄酮化合物的修饰,从而产生与Caspase蛋白家族成员更具亲和力的类黄酮类似物。
英文摘要
DESCRIPTION (provided by applicant): This project seeks to develop a rational design methodology that utilizes a powerful solvation analysis tool, WaterMap, to direct the modification of lead compounds so that they bind with greater affinity to a given target. The methodology will be applied to design modifications to flavonoid compounds so that the resulting analogues specifically and strongly inhibit members of the Caspase family of proteins. The WaterMap technology utilizes explicit molecular dynamics simulations and a rigorous statistical mechanical theoretical treatment to create an approximate 3-dimensional mapping of the chemical potential of solvation of protein active sites. This methodology addresses two well-known deficiencies in most computational methods aimed at predicting ligand-binding affinity. First, while maintaining computational efficiency, it captures essential molecular length scale physics of water solvation that most methodologies aimed at predicting ligand-protein binding affinities ignore. Second, it provides specific information and physical insight into how lead-drugs should be modified such as to produce derivatives that can bind with greater affinity and with specificity to given targets
Because of these features, the WaterMap methodology shows great promise as an aid in the lead optimization process. The rational design of flavonoid analogues that are more specific and stronger inhibitors of the caspase family of proteins will serve as a test case with the long term goal of developing a methodology that is applicable to all hydrated protein targets. Specific Aim 1 seeks to design and implement a rational design methodology that incorporates solvation information provided by the WaterMap technology that is capable of directing the design of modifications to lead compounds such that they bind with higher affinity to given targets. The assessment of Specific Aim 1 will be the goal of Specific Aim 2 which is to apply the new methodology to design modifications to flavonoid compounds that result in flavonoid analogues that bind with greater affinity to members of the Caspase family of proteins.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Solvation directed drug design: from molecular physics to lead optimization
-
批准号:10330792
-
项目类别:
-
资助金额:$37.96万
-
财政年份:2022
-
负责人:Thomas Philip Kurtzman
-
依托单位:
Solvation directed drug design: from molecular physics to lead optimization
-
批准号:10664834
-
项目类别:
-
资助金额:$37.98万
-
财政年份:2022
-
负责人:Thomas Philip Kurtzman
-
依托单位:
Solvation Directed Design of Flavonoid Derivatives for Caspase Inhibition
-
批准号:8214271
-
项目类别:
-
资助金额:$11.41万
-
财政年份:2012
-
负责人:Thomas Philip Kurtzman
-
依托单位:
Exploiting Solvation Structure and Thermodynamics for Prospective Drug Discovery and Rational Design
-
批准号:9278586
-
项目类别:
-
资助金额:$12.38万
-
财政年份:2012
-
负责人:Thomas Philip Kurtzman
-
依托单位:
Exploiting Solvation Structure and Thermodynamics for Prospective Drug Discovery and Rational Design
-
批准号:9461105
-
项目类别:
-
资助金额:$12.38万
-
财政年份:2012
-
负责人:Thomas Philip Kurtzman
-
依托单位:
Solvation Directed Design of Flavonoid Derivatives for Caspase Inhibition
-
批准号:8458118
-
项目类别:
-
资助金额:$11.01万
-
财政年份:2012
-
负责人:Thomas Philip Kurtzman
-
依托单位:
海外基金